Protein kinase C decreases the hepatocyte growth factor-induced activation of Erk1/Erk2 MAP kinases

被引:11
|
作者
Sipeki, S
Bander, E
Farkas, G
Gujdár, A
Ways, DK
Faragó, A
机构
[1] Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, H-1444 Budapest, Hungary
[2] E Carolina Univ, Dept Med, Div Endocrinol, Greenville, NC 27834 USA
基金
匈牙利科学研究基金会; 美国国家卫生研究院;
关键词
HGF; protein kinase C; Erk1/Erk2; MAP kinase cascade; cell scattering-associated protein; phosphatidylinositol; 3-kinase; c-Met; (HepG2 cells);
D O I
10.1016/S0898-6568(00)00105-4
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
HGF and phorbol ester induce the scattering of HepG2 cells. Recently, we have reported that the motility and morphological responses that accompany this process require the activation of Erk1/Erk2 MAP kinases, and phosphatidylinositol 3-kinase contributes to the activation of Erk1/Erk2 in HGF-induced cells. The cell scattering-associated appearance of a high-M-r (>300 kDa) protein pair has also been observed, and has been proven to be a sensitive marker of the intensity of Erk1/Erk2 activation. Our present study demonstrates that in HOP-induced cells protein kinase C and phosphatidylinositol 3-kinase regulate oppositely the expression of these cell scattering-associated proteins. While in phorbol ester-treated cells the sustained activation of protein kinase C is essential for this expression, in HGF-induced cells the inhibition of protein kinase C with bisindolylmaleimide I stimulates the expression. Protein kinase C reduces the HGF-induced phosphorylation of Erk1/Erk2, and in this way it can limit the intensity of Erk1/Erk2-dependent gene-expression (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:549 / 555
页数:7
相关论文
共 50 条
  • [31] HYPOXIC ACTIVATION OF NUCLEAR FACTOR-KAPPA-B IS MEDIATED BY A RAS AND RAF SIGNALING PATHWAY AND DOES NOT INVOLVE MAP KINASE (ERK1 OR ERK2)
    KOONG, AC
    CHEN, EY
    MIVECHI, NF
    DENKO, NC
    STANNBROOK, P
    GIACCIA, AJ
    CANCER RESEARCH, 1994, 54 (20) : 5273 - 5279
  • [32] Acute activation of Erk1/Erk2 and protein kinase B/akt proceed by independent pathways in multiple cell types
    Chiu, D
    Ma, K
    Scott, A
    Duronio, V
    FEBS JOURNAL, 2005, 272 (17) : 4372 - 4384
  • [33] Activation mechanism of the MAP kinase ERK2 by dual phosphorylation
    Canagarajah, BJ
    Khokhlatchev, A
    Cobb, MH
    Goldsmith, EJ
    CELL, 1997, 90 (05) : 859 - 869
  • [34] Murine hepatocyte protection by lysophosphatidie acid (LPA) is mediated via activation of MAP kinase Erk1/Erk2 cascade and PI-3 kinase/Akt/Bad dependent pathways
    Sautin, YY
    Crawford, JM
    Svetlov, SI
    FASEB JOURNAL, 2001, 15 (05): : A1177 - A1177
  • [35] Activation of ERK1/ERK2 phosphorylation by ATP in bovine chromaffin cells
    Hexum, Terry
    Luke, Toni
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 406 - 406
  • [36] Expression and activation of MAP kinases, ERK1/2, in the human villous trophoblasts
    Kita, N
    Mitsushita, J
    Ohira, S
    Takagi, Y
    Ashida, T
    Kanai, M
    Nikaido, T
    Konishi, I
    PLACENTA, 2003, 24 (2-3) : 164 - 172
  • [37] C-peptide stimulates ERK1/2 and JNK MAP kinases via activation of protein kinase C in human renal tubular cells
    Z. Zhong
    A. Davidescu
    I. Ehrén
    K. Ekberg
    H. Jörnvall
    J. Wahren
    A. V. Chibalin
    Diabetologia, 2005, 48 : 187 - 197
  • [38] C-peptide stimulates ERK1/2 and JNK MAP kinases via activation of protein kinase C in human renal tubular cells
    Zhong, Z
    Davidescu, A
    Ehrén, I
    Ekberg, K
    Jörnvall, H
    Wahren, J
    Chibalin, AV
    DIABETOLOGIA, 2005, 48 (01) : 187 - 197
  • [39] MAPK (ERK1/2) signalling in growth factor-induced lens cell proliferation
    Lovicu, FJ
    Iyengar, L
    Lynch, OT
    McAvoy, JW
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U559 - U559
  • [40] Genetic targeting of ERK1/ERK2 kinases impairs the fitness of the myeloproliferative neoplasm clone
    Stivala, Simona
    Brkic, Sime
    Dirnhofer, Stephan
    Passweg, Jakob R.
    Tsakiris, Dimitrios A.
    Neel, Benjamin G.
    Levine, Ross L.
    Meyer, Sara C.
    SWISS MEDICAL WEEKLY, 2019, 149 : 21S - 21S